Autologous DC-CIK Cells therapy (Liaoning Medical Diagnosis and Treatment Technology Research and Development)

N/A

Report date: 2026/02/05 20:00:17

Base Information

Drug NameAutologous DC-CIK Cells therapy (Liaoning Medical Diagnosis and Treatment Technology Research and Development)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumoursLung NeoplasmsLiver Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesLiaoning Medical Diagnosis and Treatment Technology Research and Development Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Medical Diagnosis and Treatment Technology Research and Development Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursLung NeoplasmsLiver Neoplasms +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A